Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 2—February 2020

Global Expansion of Pacific Northwest Vibrio parahaemolyticus Sequence Type 36

Michel Abanto, Ronnie G. Gavilan, Craig Baker-Austin, Narjol Gonzalez-Escalona, and Jaime Martinez-UrtazaComments to Author 
Author affiliations: University of La Frontera, Temuco, Chile (M. Abanto); Instituto Nacional de Salud, Lima, Peru (R.G. Gavilan); The Centre for Environment, Fisheries and Aquaculture Science, Weymouth, UK (C. Baker-Austin, J. Martinez-Urtaza); US Food and Drug Administration, College Park, Maryland, USA (N. Gonzalez-Escalona)

Main Article


Sequence type 36 isolates identified in clinical settings and from environmental sources, Lima, Peru, 2011–2016

Isolate Alias Year Source
CFSAN062371 3.369–15 2011 Environmental
CFSAN062362 1.004–13 2012 Clinical
CFSAN062300 3.252–16 2015 Clinical
CFSAN062366 1.147–15 2015 Clinical
CFSAN062373 1.146–15 2015 Clinical
CFSAN062273 1.210–16 2016 Clinical
CFSAN062350 1.166–15 2016 Clinical

Main Article

Page created: January 20, 2020
Page updated: January 20, 2020
Page reviewed: January 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.